Skip to content

Clinical trials

Alzheimer Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Country / region: Australia Clear all

169 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20043
20052
20063
20076
20089
20099
20102
20113
20125
20134
20147
20158
201610
20178
20189
20199
20206
202115
20229
20238
202411
202512
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81
Terminated45
Recruiting19
Active, not recruiting16
Unknown status4
Not yet recruiting2
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche15
Eli Lilly and Company11
Pfizer9
GlaxoSmithKline8
Washington University School of Medicine8
Alector Inc.4
Anavex Life Sciences Corp.4
Biogen4
Bristol-Myers Squibb4
Cerecin4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease169
Dementia58
Cognitive Dysfunction24
Neurodegenerative Diseases16
Brain Diseases13
Nervous System Diseases9
Central Nervous System Diseases8
Mental Disorders8
Tauopathies8
Neurocognitive Disorders7

Trials

Showing 51 to 75 of 169. Each trial links to its page on Pharma Observatory.

69 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.